Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA R428 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA alisertib CTRPv2 pan-cancer AAC 0.031 0.3
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.031 0.3
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.032 0.3
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.073 0.3
mRNA AT13387 CTRPv2 pan-cancer AAC 0.045 0.3
mRNA erastin CTRPv2 pan-cancer AAC 0.034 0.3
Download CSV